
    
      Research Design: Double-blind Randomized Placebo Controlled Trial

      Subject: Singleton pregnancy GA 34 wk or more with high risk for postpartum hemorrhage
      undergo cesarean section with spinal anesthesia in Rajavithi Hospital

      Allocated to 3 groups

        -  group1: Misoprostol sublingually 2 tab (400 mcg) + Oxytocin 20 IU Intravenous + Placebo
           Intrauterine 2 tab

        -  group2: Misoprostol Intrauterine 2 tab (400 mcg) + Oxytocin 20 IU Intravenous + Placebo
           sublingually 2 tab

        -  group3: Oxytocin 20 IU Intravenous + Placebo Intrauterine 2 tab + Placebo sublingually 2
           tab
    
  